Biologics and Biosimilars Regulations and Registration in South Korea
The Korean pharmaceutical market is estimated to be worth $24.3 billion in 2019, and between 2015 and 2019, it grew […]
Import of Biological Specimens into India
A Biological specimen is a pharmaceutical product prepared by utilizing living cells and tissues to prevent, diagnose, or treat diseases.
FSSAI Labeling Requirements For Infant Formula In India
Ensuring the safety and quality of infant formula is paramount for the health and development of infants. In India, the
Biologics and Biosimilars Regulation and Registration in India (CDSCO)
The size of the Indian biosimilars market, which was anticipated to be worth $349 million in 2022, is expected to
CDSCO Cosmetics Registration in India for Importation
India’s cosmetic market is bustling with opportunities, attracting both domestic and international players. However, entering this lucrative market requires meticulous
Updated List of Approved Fixed-Dose Combinations (FDC) from CDSCO, India
The CDSCO serves as the main authority regulating pharmaceuticals in India. To help comply with the safety, quality, and manufacturing
What Is CDSCO SUGAM Portal & Its Registration Process
The word SUGAM means “easy to approach” in Sanskrit. Just like how it means it was developed by CDSCO to
CDSCO Labeling Requirements for Cosmetics in India
The label of cosmetic products is a mode of communication between the manufacturer and the consumer. As all the essential
IVD Medical Devices Registration & Approval In India
IVDs in India are regulated as drugs under Section 3(b)(i) and 3(b)(iv) of the Drugs and Cosmetics Act, 1940. With